Abstract
This article discusses the schedule classification and effects of MDMA. The potential damage, therapeutic effects and reclassification of MDMA are examined in a new perspective that challenges past notions which lead to it's scheduling as a class one drug.
Recommended Citation
Cromer, Alison
(2013)
"Molly: The Not So Convincing Truth of MDMA,"
Sound Neuroscience: An Undergraduate Neuroscience Journal: Vol. 1:
Iss.
1, Article 17.
Available at:
https://soundideas.pugetsound.edu/soundneuroscience/vol1/iss1/17
COinS